ClearLeaf uses patent-pending technology, organic certified in the EU and Japan, to control fungi and bacteria in agriculture.
ClearLeaf has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in May 2025.
ClearLeaf's investors include Village Capital, MassChallenge, Visa Foundation, MassChallenge Switzerland, gbeta.
ClearLeaf is headquartered in Wilmington, United States.
ClearLeaf uses patent-pending technology, organic certified in the EU and Japan, to control fungi and bacteria in agriculture.
ClearLeaf is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ClearLeaf — Funding & Investors." VCBacked, May 21, 2025, https://www.vcbacked.co/company/clearleaf. Accessed July 20, 2026.
VCBacked. (2025). ClearLeaf — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/clearleaf
{{cite web |title=ClearLeaf — Funding & Investors |url=https://www.vcbacked.co/company/clearleaf |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated